Skip to content

Arbutus Biopharma Corp: filings

Every Arbutus Biopharma Corp annual and quarterly report in the SEC record with the published financial measures it tagged, 53 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-12fiscal Q2 2026371060001447028-26-000045
10-Q2026-05-13fiscal Q1 202637760001447028-26-000021
10-K2026-03-23fiscal FY 202542840001447028-26-000017
10-Q2025-11-13fiscal Q3 2025381130001447028-25-000126
10-Q2025-08-06fiscal Q2 2025381090001447028-25-000115
10-Q2025-05-14fiscal Q1 202538790001447028-25-000099
10-K2025-03-27fiscal FY 202442840001447028-25-000083
10-Q2024-11-06fiscal Q3 2024371090001447028-24-000087
10-Q2024-08-08fiscal Q2 2024371050001447028-24-000072
10-Q2024-05-02fiscal Q1 202437770001447028-24-000038
10-K2024-03-05fiscal FY 202342840001447028-24-000035
10-Q2023-11-07fiscal Q3 2023401190001447028-23-000090
10-Q2023-08-03fiscal Q2 2023401150001447028-23-000082
10-Q2023-05-04fiscal Q1 202340830001447028-23-000025
10-K2023-03-02fiscal FY 202243860001447028-23-000018
10-Q2022-11-09fiscal Q3 2022411250001447028-22-000055
10-Q2022-08-04fiscal Q2 2022411210001447028-22-000047
10-Q2022-05-05fiscal Q1 202241850001447028-22-000025
10-K2022-03-03fiscal FY 202144880001447028-22-000019
10-Q2021-11-04fiscal Q3 2021411260001447028-21-000059
10-Q2021-08-05fiscal Q2 2021411220001447028-21-000052
10-Q2021-05-05fiscal Q1 202141860001447028-21-000027
10-K2021-03-04fiscal FY 202042840001447028-21-000021
10-Q2020-11-05fiscal Q3 2020381140001447028-20-000150
10-Q2020-08-07fiscal Q2 2020381100001447028-20-000118
10-Q2020-05-11fiscal Q1 202038800001447028-20-000049
10-K2020-03-05fiscal FY 2019451250001447028-20-000038
10-Q2019-11-06fiscal Q3 2019431440001447028-19-000071
10-Q2019-08-05fiscal Q2 2019451480001447028-19-000025
10-Q2019-05-06fiscal Q1 201940840001447028-19-000015
10-K2019-03-07fiscal FY 2018421260001447028-19-000006
10-Q2018-11-07fiscal Q3 2018391240001628280-18-013909
10-Q2018-08-03fiscal Q2 2018381170001628280-18-010369
10-Q2018-05-04fiscal Q1 201832660001628280-18-005886
10-K2018-03-16fiscal FY 2017401310001628280-18-003276
10-Q2017-11-02fiscal Q3 2017331020001628280-17-010727
10-Q2017-08-03fiscal Q2 2017341060001628280-17-008044
10-Q2017-05-04fiscal Q1 201731640001628280-17-004968
10-K2017-03-22fiscal FY 2016381250001628280-17-002760
10-Q2016-11-03fiscal Q3 2016341060001628280-16-020766
10-Q2016-08-04fiscal Q2 2016341060001628280-16-018534
10-Q2016-05-04fiscal Q1 201632660001628280-16-015493
10-K2016-03-09fiscal FY 2015391270001628280-16-012462
10-Q2015-11-05fiscal Q3 2015341090001062993-15-005809
10-Q2015-08-07fiscal Q2 201531910001171843-15-004476
10-Q2015-05-06fiscal Q1 201533670001171843-15-002592
10-K2015-03-13fiscal FY 2014341150001171843-15-001398
10-Q2014-11-07fiscal Q3 201429910001171843-14-005345
10-Q2014-08-14fiscal Q2 201429880001171843-14-003980
10-Q2014-05-14fiscal Q1 201429600001171843-14-002374
10-K2014-03-28fiscal FY 201335990001171843-14-001457
20-F2013-03-27fiscal FY 201233880001193125-13-129590
20-F2012-03-27fiscal FY 201129750001193125-12-134709

Inspect the source

Entity
Arbutus Biopharma Corp / CIK 0001447028
Captured
2026-09-20T09:04:49.017Z
SEC response SHA-256
d0c406f420689ef604e97fe778a55d59191ec33b490a85e5747539352bb315a4

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001447028.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))